All In MedTech

Device Trial Radar · NCT06011148

Clinical Data Collection on Perceval S Sutureless Prosthetic Aortic Valve in the Chinese Population

Last checked: Nov 19, 2026Latest source record: Mar 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

80

Planned (sponsor's estimate)

Start

Dec 2024

Primary completion

Dec 2025

Study completion Dec 2025

Sponsor

Lead sponsor
Corcym S.r.lNot on our public-company list
Sponsor type
Industry
First posted
Aug 25, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the study is to evaluate the safety information on the Perceval S sutureless prosthetic heart valve after the implantation for aortic valve disease. The study is designed as a post-market, observational, non-interventional retrospective and prospective registry.

Conditions

  • Aortic Valve Disease

Interventions

  • Perceval S sutureless heart valveDevice

    Aortic Valve Replacement with Perceval S sutureless heart valve

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. MortalityTime frame: up to 1 year
  2. Structural valve deteriorationTime frame: up to 1 year
  3. Cerebral thromboembolismTime frame: up to 1 year

5 more outcomes with a free account

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.